Last reviewed · How we verify
Cavir
At a glance
| Generic name | Cavir |
|---|---|
| Also known as | entecavir |
| Sponsor | Hanmi Pharmaceutical Company Limited |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study of Evaluation of Cavir Tab. 0.5mg With Food Effect on Pharmacokinetics and Safety (PHASE1)
- Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |